TWD 31.95
(-10.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 548.74 Million TWD | 105.69% |
2022 | 266.78 Million TWD | -5.38% |
2021 | 281.96 Million TWD | -1.25% |
2020 | 285.52 Million TWD | 10.45% |
2019 | 258.51 Million TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 461.98 Million TWD | -3.68% |
2024 Q1 | 479.61 Million TWD | -12.6% |
2023 FY | 548.74 Million TWD | 105.69% |
2023 Q2 | 547.46 Million TWD | -1.95% |
2023 Q1 | 558.37 Million TWD | 109.3% |
2023 Q3 | 554.62 Million TWD | 1.31% |
2023 Q4 | 548.74 Million TWD | -1.06% |
2022 Q3 | 251.58 Million TWD | 0.0% |
2022 Q4 | 266.78 Million TWD | 6.04% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -328.552% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 81.083% |
Level Biotechnology Inc. | 822.67 Million TWD | 33.297% |
Sagittarius Life Science Corp | 664.72 Million TWD | 17.447% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 85.908% |
GlycoNex Incorporation | 1.55 Billion TWD | 64.661% |
VBI | 452.1 Million TWD | -21.377% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | 53.343% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 26.694% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -45.033% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 51.603% |
Visgeneer Inc. | 397.17 Million TWD | -38.162% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 85.446% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 74.584% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 37.861% |
Neith Corporation | 192.15 Million TWD | -185.579% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 90.993% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -646.007% |
Enimmune corporation | 604.82 Million TWD | 9.272% |
TaiRx, Inc. | 833.74 Million TWD | 34.183% |
CHO Pharma, Inc. | 3.08 Billion TWD | 82.218% |
EirGenix Inc. | 11.16 Billion TWD | 95.084% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 4.256% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | 67.954% |
Lin BioScience, Inc. | 3.59 Billion TWD | 84.743% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 47.762% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -82.289% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -107.343% |
Lukas Biomedical Inc. | 441.19 Million TWD | -24.379% |
RBC Bioscience Corporation | 753.79 Million TWD | 27.201% |
BiOptic Inc. | 613.77 Million TWD | 10.594% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 69.148% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 52.683% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 14.903% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 82.334% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -270.941% |
NaviFUS Corp. | 490.53 Million TWD | -11.867% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 55.23% |
Sinew Pharma Inc. | 1.36 Billion TWD | 59.751% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -3.704% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 52.751% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 66.869% |
AP Biosciences Inc | 890.75 Million TWD | 38.395% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 93.565% |
3D Global Biotech Inc. | 324.14 Million TWD | -69.289% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | 58.853% |
Intech Biopharm Corporation | 2.71 Billion TWD | 79.759% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 96.428% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -33.757% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -38.276% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 73.566% |
TCI GENE Inc. | 1.16 Billion TWD | 52.935% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -86.281% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | 59.749% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 41.732% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 21.434% |
PharmaEngine, Inc. | 3.95 Billion TWD | 86.121% |
Savior Lifetec Corporation | 3.82 Billion TWD | 85.645% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 55.38% |
OBI Pharma, Inc. | 5.6 Billion TWD | 90.208% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | 48.329% |
Acepodia, Inc. | 6.81 Billion TWD | 91.952% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 85.659% |